Results 191 to 200 of about 28,292 (266)

[Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents].

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1992
openaire   +1 more source

10‐Gingerol Alleviates Arsenic Trioxide‐Induced Cardiotoxicity: Mechanisms Involving the PI3K/AKT Pathway Revealed by Network Pharmacology and Experimental Validation

Food Science &Nutrition, Volume 14, Issue 8, August 2026.
Network pharmacology combined with in vivo and in vitro experiments identified PI3K/AKT signaling as a candidate pathway associated with the protective effects of 10‐Gingerol (10Gin) against arsenic trioxide (ATO)‐induced cardiotoxicity. 10Gin improved myocardial histopathology and cardiac systolic function in ATO‐treated mice, while attenuating ...
Bin Zheng, Hui Yin, Jiabao Chen, Xiaodong Xin, Lan Yan, Chunhua Li, Hefei Wang, Hua Zhou   +7 more
wiley   +1 more source

Comparison of Total Intravenous Anesthesia Versus Volatile Anesthesia on Arrhythmia Inducibility and Clinical Outcomes During Catheter Ablation for Ventricular Tachycardia. [PDF]

J Arrhythm
Hui J, Turnbull S, Bhaskaran A, Kumar S, Dieleman S.   +4 more
europepmc   +1 more source

The Potential Role of MicroRNAs as Cardioprotective Agents During Cardioplegia: A Preliminary Qualitative Systematic Review

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Recent advancements in gene expression studies have shed light on the role of non‐coding RNAs in negatively regulating mRNA and inhibiting mRNA translation. Given the significant impact of miRNAs on cardiovascular function, our review aims to comprehensively explore their contribution to mitigating heart injury and their ...
Maryam Baniani, Ali Dabbagh, Pourya Shokri, Firoozeh Madadi   +3 more
wiley   +1 more source

Cardiotoxicity associated with anticancer therapies for gynecological tumors. [PDF]

Front Cardiovasc Med
Yang L, Liao J, Li J, Wang Z.
europepmc   +1 more source

Novel BTK inhibitors and degraders for relapsed/refractory CLL/SLL: latest updates from ASH 2025 annual meeting. [PDF]

J Hematol Oncol
Sharma P, Jiang H, Liu D.
europepmc   +1 more source

A multicentre observational study on landiolol use, efficacy, and safety in European patients with supraventricular arrhythmia (Landi-UP). [PDF]

Eur Heart J Acute Cardiovasc Care
Dizdarevic AM, Šramko M, Mangner N, Merkely B, Zima E, Nikolaos N, Scherr D, Knotzer J, Köglberger P, Nouvaki Z, Martinek M, Hnat T, Bethlehem C, Fras Z, Goździk W, Kotanidou A, Dąbrowski W, Lesiak M, Stefanska-Wronka K, Unger M, Sus J, Klade C, Krejcy K, Bouvet O, Oravec E, Krumpl G, Siller-Matula J.   +26 more
europepmc   +1 more source

Case report on investigational modular cardiac rhythm management system: wireless communication between leadless pacemaker and subcutaneous defibrillator in cardiac sarcoidosis with limited vascular access. [PDF]

Eur Heart J Case Rep
Sughra S, Augostini R, Kahwash R.
europepmc   +1 more source

Cardiovascular and Thromboembolic Safety Signals Associated with Non-Steroidal Anti-Inflammatory Drugs Initiation: A Sequence Symmetry Analysis

Bobba SS, Rowlands E, Delmestri A, Man WY, Chen X, Li X, Saura-Lazaro A, Alhambra DP, Newby D.   +8 more
europepmc   +1 more source